eMed review
Separate the three charges
eMed’s individual program separates screening, membership and medication charges. Its employer and study arrangements require their own cost and eligibility comparison.
Our verdict
eMed may suit someone who wants at-home testing and structured follow-up alongside a prescription. Compare the selected individual agreement with the actual medicine bill before enrolling. A program subsidy, employer contribution or medication starting price should not be treated as an interchangeable total.
Disclosure: GLP Loss is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
At a glance
- Category
- Screening-led weight-management care
- Molecule
- Semaglutide
- Form
- Oral · Injection
- Prescription
- Required
- Updated
- October 2026
What it is
eMed describes a digital platform combining screening, prescribing access, medication sourcing, monitoring and lifestyle support. Its consumer health-data notice names eMed, LLC. The individual FAQ says eMed itself is not a medical provider and works with licensed clinicians. Ask which practice will assess you and handle treatment questions. The main corporate site addresses employers, including employee contributions and benefit design. Those descriptions do not establish the terms of an individual purchase. Keep the organization sponsoring care separate from the clinician prescribing and the pharmacy dispensing.
How it works
The individual page describes clinical care and app-based progress tracking. Its screening process starts with at-home blood collection and clinical review. The blood-test page describes app-guided collection, prepaid sample return and viewing results in the app. It lists markers including HbA1c, lipids, kidney and liver measures, inflammation and vitamin B12. Ask how results reach the prescriber, who explains an unexpected result and whether follow-up outside the program costs extra. A collection kit and app access are not substitutes for a clear clinical contact or a personal treatment plan.
Pricing transparency
The individual page lists a $49 one-time application and screening fee, including a blood test and clinical review. It separately advertises prescription medication from $149.99 per month, payable only if approved, and a $149.99 monthly membership fee. The drug floor does not identify a selected dose, preparation and supplied quantity at that amount. Obtain the first payment, recurring charges, medicine, delivery and any additional costs together. A monthly price label should not be used to infer a particular shipment quantity or automatic renewal date. Confirm the applicable cancellation agreement before paying.
Branded vs compounded
The FAQ identifies Wegovy, with pill and pen options. Its comparison describes a 30-day tablet supply and a 28-day injectable supply. These are supply periods, not proof of identical billing intervals or patient prices. A listed format does not guarantee its suitability for you. Ask for the actual prescription and dispensing pharmacy. The site’s trademark footer alone does not establish that another named drug is available through the individual offer.
Pros and watch-outs
What we like
- The individual page separates screening, medication and membership prices.
- At-home sample collection and return steps are described publicly.
- The program publishes follow-up and check-in information.
Watch-outs
- A medicine starting figure is not a complete ongoing bill.
- Screening does not guarantee prescription eligibility.
- Study subsidies and employer arrangements have different terms.
Sources
- Individual screening, medication and membership charges
- Individual eligibility, care, Wegovy formats and refunds
- Employer-facing program and contribution context
- Separate study subsidy, dated enrollment and transition terms
- Platform program overview
- At-home blood collection and sample-return process
- Consumer health-data notice and entity identity
- Biometric verification consent and data retention
Best for
Someone comparing an individual screening and ongoing-care arrangement, with enough information to assess its clinical contact and separate medicine costs.
Who should look elsewhere
Someone expecting a subsidized study membership to establish a current public offer, or a low medication headline to cover the entire program.
How eMed compares
A few alternatives worth a look, depending on what you’re optimizing for.
- SkinnyRx
A tirzepatide price you can check
See SkinnyRx → - Shed
Compounded pricing without a membership
See Shed → - RxSpan MD
Comparing plan terms upfront
See RxSpan MD →
More GLP-1 telehealth sellers reviews: MojoonMondaeMultiMedRxMyFastRxmyRockyMyStart Health
Pricing & provider data · Last updated October 2026
How we assessed this. This review reflects GLP Loss’s own read of eMed’s publicly-stated model — pricing transparency, clinical oversight, medication clarity, and access — against our editorial methodology. We publish no fabricated ratings or first-hand outcomes. A partnership never changes the assessment — see how we make money.
Frequently asked
- Does the advertised medication price cover the whole program?
- No single combined amount is established. The individual page labels screening, prescription medication and membership separately. Ask which charges begin immediately, which depend on approval and what the selected prescription costs. Compare the complete agreement rather than choosing one component as the total.
- Can I use an existing blood test to qualify?
- The FAQ requires eMed’s screening kit and says outside laboratory reports are not accepted. Participants must be adults, with eligibility decided by a clinician using health information and results.
- Is the study subsidy the same as individual membership?
- No. The study terms describe a conditional twelve-month program subsidy while leaving medication and associated delivery charges with participants. They also contain a March 2026 onboarding deadline, subject to change. Confirm whether that arrangement is open and applies to you; it does not establish today’s individual price.
- What happens when study participation ends?
- The study terms allow transition to then-available offerings and charges unless participation is affirmatively discontinued before transition. Ask about the notice and payment arrangement if you are in that study. This is not proof that every individual customer has the same commitment or transition rule.
- Can screening or medication purchases be refunded?
- The individual FAQ excludes product refunds after dispensing and says a blood-test kit becomes nonrefundable after shipment or a completed onboarding call. Confirm any earlier cancellation options and the membership rules separately. Do not transfer the study’s screening-fee conditions to a different agreement.
- What should I check about health and identity data?
- The consumer notice addresses health-data collection, sharing and legal rights under specified state laws. The biometric policy separately discusses identity verification, consent and retention. Ask which notices govern your clinical records and particular verification process. Those policies do not establish that all data is anonymous or that every service requires biometric collection.